EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg )

Olga P Nyssen, Guillermo J Ortega, Laimas Jonaitis iD, Ángeles Pérez-Aísa, Bojan Tepes iD, Alfredo J Lucendo iD, Javier Tejedor-Tejada iD, Renate Bumane, Ana Garre, Jose M Huguet iD, Monica Perona, Óscar Núñez und 39 weitere

Helicobacter · 2026

DOI: 10.1111/hel.70107 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Helicobacter, 2026. Verfasst von Olga P Nyssen und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autó…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Helicobacter Infections, Helicobacter pylori, Macrolides. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Health, UK Research and Innovation, EU4Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Previous antibiotic use influences Helicobacter pylori antibiotic resistance. This study evaluated how prior population‐level macrolide (especially clarithromycin) use affects H. pylori eradication success in naïve patients.

Methods

Retrospective, multicenter, ecological study. Multivariate logistic regression was performed with modified intention‐to‐treat effectiveness as the main outcome. Key variables included first‐line clarithromycin‐based treatments, therapy duration (7, 10, 14 days), proton pump inhibitor dose (low, standard, high), compliance (> 90%), and clarithromycin consumption (defined daily doses/1000 inhabitants/day, from the European Surveillance of Antimicrobial Consumption Network). Nested hierarchical models incorporated macrolide consumption, matched by year and country, and assessed the interaction between consumption and first‐line empirical treatments from the European Registry on H. pylori Management (Hp‐EuReg).

Results

The study included 27,549 naïve patients from 23 countries with macrolide consumption data from 2013 to 2022. Higher macrolide consumption, within 0 to 8 years before treatment, was associated with reduced treatment effectiveness. The eradication rate consistently decreased as macrolide consumption increased, particularly within the previous 4 years. The efficacy of triple‐clarithromycin‐metronidazole, triple‐clarithromycin‐amoxicillin, and some bismuth‐quadruple therapies containing clarithromycin decreased with higher macrolide consumption. At the country level, higher population consumption of clarithromycin 2 years before treatment was associated with a decrease in eradication rates from 93% to 82%.

Conclusion

Higher macrolide consumption in the general population negatively impacts the effectiveness of first‐line H. pylori regimens. These findings support that clarithromycin should only be administered as a susceptibility‐based therapy, with the strongest negative impact of prior population‐level exposure observed within 5 years and diminishing thereafter. ClincialTrials.gov number, NCT02328131.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriMacrolidesAdultAgedFemaleHumansMaleMiddle AgedClarithromycinDrug Resistance, BacterialDrug Therapy, CombinationEuropeProton Pump InhibitorsRegistriesRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

H. pyloriantibiotic consumptionclarithromycineradication treatmentmacrolideresistance

Substanzen

Anti-Bacterial AgentsClarithromycinMacrolidesProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid(UAM), and Centro de Investigación Biomédica en Red de E…
  • Unidad de Análisis de Datos, Hospital Universitario de la Princesa, CONICET, Universidad Nacional de Quilmes-Argentina, Madrid, Spain.
  • Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Gastroenterology, Hospital Universitario Costa del Sol, RICAPPS Red de Investigación en Cronicidad, Atención Primaria y Prevención y Promoción de la Salud, Marbella, Spain.
  • Department of Gastroenterology, DC Rogaska, Slatina, Slovenia.
  • Department of Gastroenterology, Hospital General de Tomelloso, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), In…

ORCID-Profile: Laimas Jonaitis, Bojan Tepes, Alfredo J Lucendo, Javier Tejedor-Tejada, Jose M Huguet, Miguel Areia, Manuel Domínguez Cajal, György Miklós Buzás, Samuel J Martínez-Domínguez, Sinead M Smith, Pablo Parra, Francis Mégraud

Förderung

  • HORIZON EUROPE Health
  • UK Research and Innovation
  • EU4Health

Zitieren

APA

Nyssen, O. P., Ortega, G. J., Jonaitis, L., Pérez-Aísa, Á., Tepes, B., Lucendo, A. J., Tejedor-Tejada, J., Bumane, R., Garre, A., Huguet, J. M., Perona, M., Núñez, Ó., Pabón-Carrasco, M., Castro-Fernández, M., Areia, M., Barrio, J., Loro, A. M., Butler, T. J., Marcos, M. S., …, & Hp‐EuReg investigators (2026). Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg ). Helicobacter. https://doi.org/10.1111/hel.70107

Vancouver

Nyssen OP, Ortega GJ, Jonaitis L, Pérez-Aísa Á, Tepes B, Lucendo AJ, et al. Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg ). Helicobacter. 2026. doi:10.1111/hel.70107

BibTeX
@article{Nyssen2026,
  author = {Nyssen, Olga P and Ortega, Guillermo J and Jonaitis, Laimas and Pérez-Aísa, Ángeles and Tepes, Bojan and Lucendo, Alfredo J and Tejedor-Tejada, Javier and Bumane, Renate and Garre, Ana and Huguet, Jose M and Perona, Monica and Núñez, Óscar and Pabón-Carrasco, Manuel and Castro-Fernández, Manuel and Areia, Miguel and Barrio, Jesús and Loro, Antonio Moreno and Butler, Thomas J and Marcos, María Soledad and Keco-Huerga, Alma and Cajal, Manuel Domínguez and Denkovski, Maja and Pavoni, Matteo and Buzás, György Miklós and Lerang, Frode and Losurdo, Giuseppe and Wolfe García, Pablo M and Phull, Perminder S and Martínez-Domínguez, Samuel J and Kupcinskas, Juozas and Leja, Mārcis and Marcos-Pinto, Ricardo and Smith, Sinead M and Gasbarrini, Antonio and Papp, Veronika and Rodríguez, Blas José Gómez and Alonso, Mónica Sánchez and Villarroya, Ramón Pajares and Mejide, Pilar Pazo and Jiménez-Moreno, Manuel and Pascual-Mato, Marta and Bravo-Pache, Concepción and Montes, Milagrosa and Cano-Català, Anna and Parra, Pablo and Moreira, Leticia and Mégraud, Francis and O'Morain, Colm and Bujanda, Luis and Gisbert, Javier P and Hp‐EuReg investigators, Hp‐EuReg investigators},
  title = {Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg )},
  journal = {Helicobacter},
  year = {2026},
  doi = {10.1111/hel.70107}
}
Kostenlos starten →